about
Hepcidin--the iron regulatory hormone.Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidinHepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic micePosttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furinPathophysiology of hereditary hemochromatosisHepcidin in the diagnosis of iron disordersLaboratory use of hepcidin in renal transplant recipientsIneffective erythropoiesis in β -thalassemiaHepcidin and iron homeostasisMechanisms of mammalian iron homeostasisBMP signaling modulates hepcidin expression in zebrafish embryos independent of hemojuvelinHepcidin and iron regulation, 10 years later.Alpha-1 antitrypsin binds preprohepcidin intracellularly and prohepcidin in the serumIdentification of erythroferrone as an erythroid regulator of iron metabolismMolecular biology, genetics and biochemistry of the repulsive guidance molecule familyIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesNeogenin inhibits HJV secretion and regulates BMP-induced hepcidin expression and iron homeostasisHydroxyurea could be a good clinically relevant iron chelator17β-Estradiol inhibits iron hormone hepcidin through an estrogen responsive element half-siteA novel immunological assay for hepcidin quantification in human serumFerroportin1 is required for normal iron cycling in zebrafishIron overload in sickle cell disease.Reduction of serum hepcidin by hemodialysis in pediatric and adult patients.Cardiac iron across different transfusion-dependent diseases.Spleen R2 and R2* in iron-overloaded patients with sickle cell disease and thalassemia major.Iron overload cardiomyopathy: better understanding of an increasing disorder.Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I.A chemical screen identifies small molecules that regulate hepcidin expression.Gender-related variations in iron metabolism and liver diseases.Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia.Hepcidin induction by transgenic overexpression of Hfe does not require the Hfe cytoplasmic tail, but does require hemojuvelin.Iron metabolism in thalassemia and sickle cell diseaseOf mice and men: the iron age.Iron imports. IV. Hepcidin and regulation of body iron metabolism.Gastrins, iron homeostasis and colorectal cancerIntestinal hypoxia-inducible factor-2alpha (HIF-2alpha) is critical for efficient erythropoiesisHypoxia-inducible factor-2α mediates the adaptive increase of intestinal ferroportin during iron deficiency in miceHepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait.Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in miceCombination therapy with a Tmprss6 RNAi-therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of β-thalassemia intermedia.
P2860
Q24536439-D1CCF57B-0B42-4940-B050-6B9B6F7DB8FBQ24632978-A6AA3A9B-F2CC-4DCF-8F9B-E1C9036AE029Q24633423-92CA0575-D461-42C2-9C27-0DDE243709E2Q24648028-0DA02514-09CC-4DE2-A523-18A64F6AB3D0Q24654441-CF57E771-3AA2-4785-8C44-182CA118977EQ26752500-5F257B47-0BDB-4CF8-AF40-21460ECDA6FAQ26765316-D7D7ABB6-6EBC-420F-93CE-44809CDE9AFEQ26830255-A316A824-095A-4CE0-9A78-F7859DFDFB9FQ27002595-3AAAF9F5-9AD0-4B6A-B296-5E8376FA1DA7Q27010510-EE49ABD3-2616-451F-8539-AC65361463FBQ27314712-4201EFE5-C316-4DE6-AC8E-64B1DBE22E1AQ27690828-5EB44E97-27CE-442F-B61D-35F20F911AFDQ28238363-91B58118-F305-4347-A889-6ADD28B29F6CQ28240988-639B4A8A-9302-4233-85DD-4F7430808288Q28255922-F661A4D2-F545-4B3E-B8E6-9C49F2259B91Q28388335-B418A7B0-1855-4257-AA98-FB1880415FD3Q28509930-AD13BD01-38AE-463F-9F4D-E3ADE9B897BEQ28536619-5C9CB50B-8A0D-40FE-8CB7-28D7124E063FQ28728196-FF51640C-DA21-4034-A464-7458C4BA6E12Q33411750-7F7BCF9C-C706-40E2-BCD6-11624B896699Q33774889-B034760F-DFEC-42C8-BBA7-DDC6A9B68667Q33861129-37D1E5E6-6A0B-4AB9-9007-768587140DBBQ33888363-C2C8DF0C-C017-4D3D-A5C5-D01FA50E5A45Q33958560-E4655C07-BD8C-439E-BD1D-588CD74AAE82Q34004503-502DE2DC-F6A6-44F2-85DA-0531B301EED2Q34165921-E09508DC-9DE7-47F1-A05A-F1E54CD210E0Q34197725-43B885F4-9F89-4437-83BA-D5408E638BB2Q34345426-94868167-49EA-4981-9D6F-7AC382180E0BQ34391646-8B38AC05-88AE-47AD-BEC7-8021AABC55BAQ34489655-7DAF4546-5890-463C-80E3-02400CA381D4Q34541753-563091B8-811A-4C98-9829-B88B6C144E13Q34549409-4924B657-0D72-42C7-B6EE-C4ABFBC60B44Q34650865-BA6532B2-7FCE-4F11-9D9F-6B2ED76E5B72Q34651570-A1592128-DF58-4BDB-8178-526337CFEF5BQ34810044-AA90B9B0-AE42-46AC-9FFD-7C7256BC3DA1Q35010977-DB9C8C41-BD15-41A6-BAB8-83691064684EQ35027929-AC4694C7-BC5F-4F8E-BC55-5F182A683425Q35062875-CBA77C30-FE40-4891-BA5E-36FB24B6EDD2Q35483789-30AF5634-1100-40C9-874A-94D1B9919169Q35495166-2CC572BF-B4C2-4AB9-97DA-74AC91CB0471
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Hepcidin in iron overload disorders
@ast
Hepcidin in iron overload disorders
@en
type
label
Hepcidin in iron overload disorders
@ast
Hepcidin in iron overload disorders
@en
prefLabel
Hepcidin in iron overload disorders
@ast
Hepcidin in iron overload disorders
@en
P2093
P2860
P1433
P1476
Hepcidin in iron overload disorders
@en
P2093
Dionisios Bogdanos
Elizabeta Nemeth
John I Christakis
Julie MacFarlane
Konstantina Tsimirika
Michalis Tzilianos
Nikos Sakellaropoulos
Y Paul Goldberg
P2860
P304
P356
10.1182/BLOOD-2004-12-4844
P407
P577
2005-01-25T00:00:00Z